Navigation Links
Scientists reveal molecular secrets of the malaria parasite

In an innovative project with implications for malaria vaccine development, scientists have used genomics, proteomics and gene expression studies to trace how malaria parasites evolve on a molecular level as they move between their hosts and insect vectors. That focus on the parasites' complex life cycle is helping researchers understand when different genes switch on and off as the pathogens metamorphose through seven different life stages. In turn, that molecular-level data may benefit biomedical scientists who are identifying new targets for vaccines that would impede the parasite during stages when it is particularly vulnerable to intervention.

"We hope this project will help vaccine researchers find the best targets against malaria," says scientist Neil Hall, the first author of the paper that appears in the January 7th issue of Science. "The study's findings will help scientists identify parasite genes that are interacting with the host as well as new gene targets for vaccines that aim to prevent parasite transmission in the mosquito." The study highlights the genes in four malarial species that evolve rapidly because of "selective pressures" in the stages of their life cycles in their mosquito vectors and in their mammalian hosts. Malaria parasites undergo three stages in their mosquito vectors, three stages in their vertebrate hosts and a sexual development stage during which the parasite is transmitted between vector and host. The Science paper represents the culmination of four years of cooperative work by scientists at several research institutes, including: the Wellcome Trust Sanger Institute in the U.K., where the sequencing and genome annotation was performed on two species of rodent malaria (Plasmodium chabaudi and P. berghei); the University of Leiden in the Netherlands and Imperial College in England, where scientists carried out gene expression studies; and The Institute for Genomic Research (TIGR), in Maryland, where scientists did a compa
'"/>

Source:Eurekalert


Page: 1 2 3

Related biology news :

1. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
2. Scientists Replicate Hepatitis C Virus in Laboratory
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Scientists find missing enzyme for tuberculosis iron scavenging pathway
5. Scientists seek answers on what activates deadly anthrax spores
6. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
7. Scientists collaborate to assess health of global environment
8. Scientists decipher genome of fungus that can cause life-threatening infections
9. Scientists discover the cellular roots of graying hair
10. Scientists rid stem cell culture of key animal cells
11. Scientists develop new color-coded test for protein folding

Post Your Comments:
(Date:11/6/2009)...FAIRFAX, Va.Registration is now open for the Socie...erventional Oncology (IO) Therapies" Webinar, whic...and transcatheter treatment of liver tumors, kidne... national organization of physicians, scientists a...ing public health through pioneering advances in i...
(Date:11/6/2009)..., DETROIT, Nov. 6 Auburn Hills, ...(LEID) will be installing its locker system and pa...BACS) at the U.S. Department of Health and Human S... in Bethesda, MD. The locker system will support ...for protecting our nation,s medical research agenc...
(Date:11/5/2009)...New Haven, Conn.Researchers at Yale University hav...ng the body,s immune response to HIV and HIV-infec...eir findings, published online in the Journal of ...l therapeutic approaches for these diseases. , ...e targeting HIV" (ARM-H) and "antibody-recruiting ...
Breaking Biology News(10 mins):Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz CA 5343 1Satellite Healthcare Tees Up With the National Kidney Foundation in Santa Cruz CA 5343 2Mirixa Corporation Announces Key Pharmacy Network Hire 5339 1Mirixa Corporation Announces Key Pharmacy Network Hire 5339 2Newly Updated Pharmacy State Law Compendium Available 5335 1Newly Updated Pharmacy State Law Compendium Available 5335 2
... NYU Langone Medical Center scientists and their ... La Jolla, Calif., have discovered an unexpected c...l meningitis, an infection of the central nervous ...nal Nature. The finding may lead to a new way of t... to viral diseases. , The NYU researchers, Michae...
...adly form of malaria for humans, Plasmodium falci...nzees, this group has been fairly isolated on the ...analysis from the Sackler Institute for Comparativ...ry reveals that malarial parasites found in tree-d...ip with P. falciparum and Plasmodium reichenowi...
...tains, from the Apennines to the Alps, have fascin... Walter Alvarez for more than 35 years, resulting ... that traces Italy,s billion-year geologic history...ndbreaking - and often overlooked - discoveries. ,...n & Company, Inc. Alvarez, a UC Berkeley professor...
Other Biology News:Peering inside the skull of a mouse to solve meningitis mystery 2Peering inside the skull of a mouse to solve meningitis mystery 3African thicket rat malaria linked to virulent human form 2Italy's geologic history becomes a personal tale in Walter Alvarez's new book 2Italy's geologic history becomes a personal tale in Walter Alvarez's new book 3Italy's geologic history becomes a personal tale in Walter Alvarez's new book 4
(Date:11/5/2009)... 5 GenVec, Inc. (Nasdaq:... the third quarter ended September 30, 2009. GenVe...hare) for the three months ended September 30, 200...r share) in the comparable quarter of 2008. For th...et loss was $14.1 million ($0.15 per share), compa...
(Date:11/5/2009)... Nov. 5 ThermoGenesis Co...tive products for processing and storing adult ste...ter of fiscal 2010. ,, For the quarter ended Se... $5.2 million, a 15 percent increase over revenues...The Company said the key contributors to the growt...
(Date:11/5/2009)... 5 Cepheid (Nasdaq: CPH...eaking at the following investor conferences, and ... Credit Suisse Healthcare Conferenc...ber, 2009 at 10 a.m. Mountain Time, ...nd, Tuesday, 1 December, 2009 at 1...
(Date:11/5/2009)...PRNewswire/ -- SpineSmith Partners has signed an i... a unique scaffold that mimics the structure of na...veral commercial products by SpineSmith,s Research...the GenOsteo scaffold represents a significant adv...deal environment for the delivery of adult stem ce...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
...ology To Potentially Improve ...7 Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) toda...arch and License Agreement with Genentech, Inc. ex...ional targets for potential improvement,of product...nger,DNA-binding protein nuclease (ZFN) technology...
...Group,(Debiopharm), a global independent biopharma...s medical conditions and particularly oncology, to...cology chair at the Ecole,Polytechnique Federale d...,in Oncogenesis. Funded through a CHF 2.5 million ...ge the wide scope of ideas and inventions,discover...
...generate antibodies against novel resea...rmany and ST. LOUIS, Feb. 27 ,Sigma-Aldrich(TM) (N...xchange: MOR; Prime Standard Segment, TecDAX) toda...roduce and distribute unique,recombinant research ...D(R),technology. MorphoSys,s AbD Serotec unit will...
Other Biology Technology:Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production 2Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production 3Debiopharm and EPFL Establish an Oncology Chair 2Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies 2Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies 3
... identified as the cellular homolog of the avian s...been shown to be almost identical to c-Jun in thei...zation and DNA binding, whereas their N-terminal d...vation, diverge. Antigen: The antibody was pro...
Mouse Anti-Yersinia pestis Capsular F1 Antigen Monoclonal Antibody, Unconjugated, Clone YBF19 from QED Bioscience Inc.
Rabbit Anti-JMJD2D Polyclonal Antibody, Unconjugated from Abcam
Perm/Wash Buffer from BD Biosciences Pharmingen
Biology Products: